Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Update on vaccine-derived polioviruses detected worldwide, April 2011–June 2012.

[No authors listed]

Wkly Epidemiol Rec. 2012 Sep 21;87(38):358-68. English, French. No abstract available.

2.

Reaching the last one per cent: progress and challenges in global polio eradication.

Kew O.

Curr Opin Virol. 2012 Apr;2(2):188-98. doi: 10.1016/j.coviro.2012.02.006. Epub 2012 Mar 7. Review.

PMID:
22482715
3.

Changing poliovirus vaccine policy can be controversial at best.

Faden H.

Adv Pediatr Infect Dis. 1997;13:305-32. Review. No abstract available.

PMID:
9544317
5.

Circulating vaccine-derived polioviruses: current state of knowledge.

Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA.

Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Review.

6.

[Eradication of poliomyelitis and emergence of pathogenic vaccine-derived polioviruses: from Madagascar to Cameroon].

Delpeyroux F, Colbère-Garapin F, Razafindratsimandresy R, Sadeuh-Mba S, Joffret ML, Rousset D, Blondel B.

Med Sci (Paris). 2013 Nov;29(11):1034-41. doi: 10.1051/medsci/20132911021. Epub 2013 Nov 20. Review. French.

7.

[How poliomyelitis is to be eradicated completely].

Seĭbil' VB.

Zh Mikrobiol Epidemiol Immunobiol. 2002 Mar-Apr;(2):107-13. Review. Russian.

PMID:
12043142
8.

Outbreaks of paralytic poliomyelitis, 1976-1995.

Patriarca PA, Sutter RW, Oostvogel PM.

J Infect Dis. 1997 Feb;175 Suppl 1:S165-72. Review.

PMID:
9203711
9.

Vaccine-derived polioviruses.

Burns CC, Diop OM, Sutter RW, Kew OM.

J Infect Dis. 2014 Nov 1;210 Suppl 1:S283-93. doi: 10.1093/infdis/jiu295. Review.

PMID:
25316847
10.

[Possible method of eradication of poliomyelitis as an infection].

Seĭbil' VB, Malyshkina LP.

Zh Mikrobiol Epidemiol Immunobiol. 2012 May-Jun;(3):107-13. Review. Russian.

PMID:
22830285
11.

Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge.

Hird TR, Grassly NC.

PLoS Pathog. 2012;8(4):e1002599. doi: 10.1371/journal.ppat.1002599. Epub 2012 Apr 19. Review.

12.

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.

Alexander JP Jr, Gary HE Jr, Pallansch MA.

J Infect Dis. 1997 Feb;175 Suppl 1:S176-82. Review.

PMID:
9203713
13.

[The lost decade of global polio eradication and moving forward].

Shimizu H.

Uirusu. 2010 Jun;60(1):49-58. Review. Japanese.

15.

[End phase challenges of poliomyelitis eradication programme realization].

Jarzabek Z.

Przegl Epidemiol. 2005;59(1):59-68. Review. Polish.

PMID:
16013411
16.

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

Thompson KM, Tebbens RJ.

Expert Rev Vaccines. 2012 Apr;11(4):449-59. doi: 10.1586/erv.11.195. Review.

PMID:
22551030
17.

Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.

Pliaka V, Kyriakopoulou Z, Markoulatos P.

Expert Rev Vaccines. 2012 May;11(5):609-28. doi: 10.1586/erv.12.28. Review.

PMID:
22827246
18.

The Challenge of Global Poliomyelitis Eradication.

Garon JR, Cochi SL, Orenstein WA.

Infect Dis Clin North Am. 2015 Dec;29(4):651-65. doi: 10.1016/j.idc.2015.07.003. Review.

PMID:
26610419
19.

Control of poliomyelitis: a continuing paradox.

Horstmann DM.

J Infect Dis. 1982 Oct;146(4):540-51. Review. No abstract available.

PMID:
6288809
20.

[Poliomyelitis vaccine].

Horie H.

Nihon Rinsho. 2005 May;63 Suppl 5:601-6. Review. Japanese. No abstract available.

PMID:
15954416

Supplemental Content

Support Center